Summary

Overview
Global Reflux Testing Devices Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.
Reflux testing devices are used to diagnose gastroesophageal reflux disease (GERD) and other disorders related to abnormal reflux of stomach contents into the esophagus. These tools help medical professionals in monitoring and measuring the frequency and length of acid reflux episodes, evaluating the condition's severity, and selecting the best course of action.
This examination gauges the esophageal pH throughout the span of a day. A small devices worn around the waist is attached to a thin tube that is put through the nose and into the oesophagus. Doctors can assess the frequency and length of acid reflux episodes with the use of the gadget, which captures information on the levels of acid in the oesophagus.
Market Dynamics: Drivers and Restraints
The increasing technological advancements
Reflux testing technology are continually improving, which results in the development of more precise, minimally invasive, and patient-friendly equipment. Both people and healthcare providers are drawn to these advancements, which accelerates market expansion. For instance, in April 2023, Laborie Medical Technologies Corp. (Laborie), a market lead in diagnostic and therapeutic medical technology, recently introduced the alpHaONE system, which is specifically made to diagnose gastroesophageal reflux disease (GERD) and provides up to 96 hours of monitoring data.
The addition of the alpHaONE wireless pH-capsule reflux testing device strengthens Laborie's dedication to expanding the range of diagnostic options for esophageal illnesses. Additionally, the demand for reflux testing devices is strongly impacted by the increasing prevalence of GERD and related diseases.
The market for reflux testing devices is driven by the demand for precise diagnosis and monitoring as GERD prevalence rises globally. Both patients and healthcare professionals favour minimally invasive or non-invasive diagnostic techniques. There is a great demand for reflux testing equipment that provides precise results without discomfort or effects.
Market Dynamics: Restraint
The market for reflux testing devices could encounter limitations on expansion due to various causes. For instance, reflux testing devices, particularly advanced and novel ones, might be costly. Their widespread use may be constrained by their expensive price, particularly in countries with constrained healthcare budgets or among patients without adequate insurance coverage.
In addition, there are many approaches that healthcare professionals could employ instead of reflux testing, such as symptom-based diagnosis or empirical treatment. The market for reflux testing devices may be constrained if these alternatives are shown to be adequate in some circumstances. Financial challenges and political unrest in some areas may result in lower healthcare spending, which may limit the use of expensive diagnostic techniques like reflux testing.
For more details of the report, Request for sample
Segment Analysis
The global reflux testing devices market is segmented based on product type, application, age group, end-user and region.
The reflux capsule segment from the type segment accounted for approximately 41.7% of reflux testing devices market
The diagnosis of gastroesophageal reflux disease (GERD) and other esophageal problems associated with acid play a critical role in the use of capsule-based pH reflux testing systems, also known as wireless pH monitoring systems. These systems are crucial to the practise of gastroenterology and patient care for a number of reasons.
For instance, capsule-based devices are non-invasive in contrast to conventional pH monitoring techniques that call for a nasogastric tube. Patients ingest a tiny wireless capsule that measures the pH levels in their oesophagus continually. This allows for simpler and natural testing circumstances. Additionally, acid-reducing drugs and other therapies are assessed for their effectiveness using capsule-based pH reflux testing methods.
Healthcare professionals can evaluate the effectiveness of the recommended therapies and make the necessary changes to the treatment plan by comparing pH data from before and after treatment. Thus, the segment's features contribute to the segments growth.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
Due to factors like elevated expenditure on healthcare, expanding R&D, and an increase in GERD prevalence, North America is predicted to grow over the forecast period. The main factor propelling the market's expansion is the growing ageing population in the United States.Globally, GERD is a widespread disorder that affects many people, while it is more prevalent in western nations, particularly the United States.
According to a Nissen Fundoplication article that published in the National Library of Medicine in July 2022, GERD is the condition with the highest prevalence in the country, affecting 18.1% to 27.8% of people.
It is expected that the nation's high prevalence of diseases will open up new market prospects for reflux testing devices and accelerate market growth.
Additionally, there is a rise in risk factors for GERD include poor food, obesity, and stress as the Asia-Pacific area experiences fast urbanisation and lifestyle changes. Due to the increased prevalence of GERD caused by these lifestyle changes, reflux testing devices must be used for an accurate diagnosis.
COVID-19 Impact Analysis
Due to supply chain difficulties brought on by lockdown limitations during the early stages of the COVID-19 pandemic, there was an impact on the market. Additionally, the lockdown and isolation had an impact on people's eating patterns around the world, and individuals began overeating, which led to a rise in gastroesophageal reflux disease (GERD) instances. Additionally, investigations showed that COVID-19 had a negative impact on persons with GERD.
For instance, GERD symptoms have been linked to a high risk for COVID-19, according to a February 2022 publication in the Human Molecular Genetics Journal. Therefore, during the pandemic, the COVID-19 has increased demand for reflux testing devices. As a result, the market increased significantly during the pandemic.
Market Segmentation
By Product Type
• Reflux capsule
• Reflux probe
• Reflux catheter
By Application
• GERD Diagnosis
• Monitoring of Treatment Efficacy
• Research and Development
By Age Group
• Pediatric (Children)
• Adult
By End-User
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Laborie Medical Technologies Corp, Medtronic Plc, Medical Device Business Services, Inc, EB Neuro S.p.A, Thermo Fisher Scientific Inc, Diversatek, Inc, Chongqing Jinshan Science & Technology, Creomedical, Standard Instruments Co. Ltd, Medica S.p.A and among others.
Why Purchase the Report?
• To visualize the global reflux testing devices market segmentation based on product type, application, age group, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of reflux testing devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global reflux testing devices market report would provide approximately 69 tables, 58 figures and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by Age Group
3.4. Snippet by End-User
3.5. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing technological advancements of the devices
4.1.1.2. The strategies adopted by the companies
4.2. Restraints
4.2.1.1. Expensive cost associated with the product
4.2.2. Opportunity
4.2.3. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Unmet Needs
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Reflux capsule *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Reflux probe
7.4. Reflux catheter
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. GERD Diagnosis *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Monitoring of Treatment Efficacy
8.4. Research and Development
9. By Age Group
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
9.1.2. Market Attractiveness Index, By Age Group
9.2. Pediatric*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Adult
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals and Clinics *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Ambulatory Surgical Centers
10.4. Home Care Settings
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Laborie Medical Technologies Corp *
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Medtronic Plc
13.3. Medical Device Business Services, Inc
13.4. EB Neuro S.p.A
13.5. Thermo Fisher Scientific Inc
13.6. Diversatek, Inc
13.7. Chongqing Jinshan Science & Technology
13.8. Creomedical
13.9. Standard Instruments Co. Ltd
13.10. Medica S.p.A
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us